We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neonatal Hypoglycemia.
- Authors
Edmundson, Kiley; Jnah, Amy J.
- Abstract
Neonatal hypoglycemia (NH) is broadly defined as a low plasma glucose concentration that elicits hypoglycemia-induced impaired brain function. To date, no universally accepted threshold (reference range) for plasma glucose levels in newborns has been published, as data consistently indicate that neurologic responses to hypoglycemia differ at various plasma glucose concentrations. Infants at risk for NH include infants of diabetic mothers, small or large for gestational age, and premature infants. Common manifestations include jitteriness, poor feeding, irritability, and encephalopathy. Neurodevelopmental morbidities associated with NH include cognitive and motor delays, cerebral palsy, vision and hearing impairment, and poor school performance. This article offers a timely discussion of the state of the science of NH and recommendations for neonatal providers focused on early identification and disease prevention.
- Subjects
HYPOGLYCEMIA treatment; DIAGNOSIS of brain diseases; BLOOD sugar analysis; CONTINUING education units; RISK assessment; REFERENCE values; MEDICAL protocols; GLUCOSE; HOMEOSTASIS; BLOOD collection; ELECTROENCEPHALOGRAPHY; NEONATAL diseases; HYPERINSULINISM; BUCCAL administration; PHARMACEUTICAL gels; DIAZOXIDE; MAGNETIC resonance imaging; INFANT nutrition; NEUROLOGICAL disorders; BLOOD sugar; AMERICAN Academy of Pediatrics; INTRAVENOUS therapy; ENTERAL feeding; PSYCHOLOGICAL stress; EARLY diagnosis; EVIDENCE-based medicine; QUALITY assurance; HYPOGLYCEMIA; GLUCAGON; DISEASE risk factors; DISEASE complications; SYMPTOMS; CHILDREN
- Publication
Neonatal Network, 2024, Vol 43, Issue 3, p156
- ISSN
0730-0832
- Publication type
Article
- DOI
10.1891/NN-2023-0068